Cargando…
Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies
Carcinoid syndrome represents a debilitating paraneoplastic disease, caused by the secretion of several substances, occurring in about 10–40% of patients with well-differentiated neuroendocrine tumors (NETs). The main signs and symptoms associated with carcinoid syndrome are flushing, diarrhea, hypo...
Autores principales: | Vitale, Giovanni, Carra, Silvia, Alessi, Ylenia, Campolo, Federica, Pandozzi, Carla, Zanata, Isabella, Colao, Annamaria, Faggiano, Antongiulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961914/ https://www.ncbi.nlm.nih.gov/pubmed/36835022 http://dx.doi.org/10.3390/ijms24043610 |
Ejemplares similares
-
Immune Checkpoint Blockade in Lung Carcinoids with Aggressive Behaviour: One More Arrow in Our Quiver?
por: Di Molfetta, Sergio, et al.
Publicado: (2022) -
Diabetes and Cancer
por: Colao, Annamaria, et al.
Publicado: (2011) -
What Lies behind Paraneoplastic Hypercalcemia Secondary to Well-Differentiated Neuroendocrine Neoplasms? A Systematic Review of the Literature
por: Giannetta, Elisa, et al.
Publicado: (2022) -
Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications
por: Vitale, Giovanni, et al.
Publicado: (2021) -
Editorial—Special Issue: Foreword to the Special Issue on NIKE: Neuroendocrine Tumors, Innovation in Knowledge and Education
por: Faggiano, Antongiulio, et al.
Publicado: (2021)